论文部分内容阅读
1病历资料患者女,20岁,2012年3月确诊急性髓系白血病(AML)-M2a。患者2012-06-02第2次巩固化疗入院。3个月前因无诱因乏力、头晕、三系减低、补充造血物质无效入院,血常规示:白细胞(WBC)2.98×109/L,血红蛋白(Hb)59 g/L,血小板(PLT)23×109/L;骨髓形态:粒系0.685,原粒Ⅰ+Ⅱ占0.345;白血病免疫分型:原始区域细胞占有核
1 patient data Patient female, 20 years old, March 2012 confirmed acute myeloid leukemia (AML) -M2a. Patient 2012-06-02 Second solidification chemotherapy admission. 3 months ago, there was no predisposing factor, dizziness, three-line reduction, and the addition of hematopoietic substances was ineffective. The blood showed: WBC 2.98 × 109 / L, hemoglobin 59 g / L and PLT 23 × 109 / L; bone marrow morphology: grain 0.685, protoplast Ⅰ + Ⅱ accounted for 0.345; leukemia immunophenotype: the nucleus of primitive cells